Evaluation of the Effectiveness of the Teen Options to Prevent Pregnancy (T.O.P.P.) Program
Overview
The purpose of this study is to evaluate the effectiveness of the Teen Options to Prevent Pregnancy (T.O.P.P.) program in increasing contraceptive use and reducing repeat pregnancies among pregnant and parenting adolescents in central Ohio.
Study Type
- Study Type: Interventional
- Study Design
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Primary Purpose: Prevention
- Masking: None (Open Label)
- Study Primary Completion Date: September 2016
Detailed Description
The risk for teen pregnancy is especially high among teen mothers, leading, in some cases, to unsafe intervals between teen births. The Teen Options to Prevent Pregnancy (T.O.P.P.) program is an 18-month clinic-based program that aims to reduce repeat pregnancies among pregnant and parenting adolescents by providing telephone-based care coordination and mobile contraceptive services to this high-risk population. This study uses a randomized controlled design to compare the effectiveness of T.O.P.P. versus usual care provided to patients at participating clinics. Study participants will be adolescent mothers between the ages of 10 to 19 recruited through seven OhioHealth women's health clinics and three OhioHealth hospitals covering seven counties in central Ohio. This study is being conducted as part of the national Evaluation of Adolescent Pregnancy Prevention Approaches funded by the U.S. Department of Health and Human Services' Office of Adolescent Health.
Interventions
- Behavioral: Teen Options to Prevent Pregnancy (T.O.P.P.)
- Telephone-based care coordination and mobile contraceptive services
Arms, Groups and Cohorts
- Experimental: Teen Options to Prevent Pregnancy
- No Intervention: Usual care services
Clinical Trial Outcome Measures
Primary Measures
- Incidence of repeat pregnancy
- Time Frame: 30 months after baseline
Secondary Measures
- Contraceptive Use
- Time Frame: 6 months after baseline
- Contraceptive Use
- Time Frame: 18 months after baseline
- Contraceptive Use
- Time Frame: 30 months after baseline
Participating in This Clinical Trial
Inclusion Criteria
- 10 – 19 years old – Female – 28 weeks pregnant through 8 week post partum – Medicaid recipient – English speaking – Patient of OhioHealth
Gender Eligibility: Female
Minimum Age: 10 Years
Maximum Age: 19 Years
Are Healthy Volunteers Accepted: No
Investigator Details
- Lead Sponsor
- Mathematica Policy Research, Inc.
- Collaborator
- OhioHealth Research and Innovation Institute
- Provider of Information About this Clinical Study
- Sponsor
- Overall Official(s)
- Brian Goesling, PhD, Principal Investigator, Mathematica Policy Research
- Jack Stevens, PhD, Principal Investigator, Nationwide Children’s Hospital
- Ngozi Osuagwu, MD, Principal Investigator, OhioHealth
- Kimberly V Smith, PhD, Principal Investigator, Mathematica Policy Research
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.